Haisco Pharmaceutical Group Co Ltd (002653):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Haisco Pharmaceutical Group Co Ltd (002653) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8238
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive system drugs and tumor adjuvant drugs. Its parenteral nutrition drugs include compound amino acid injection, injectable fat-soluble vitamins, vitamin and trace element drug, invert sugar injection, trace element injection and injectable fat soluble vitamins. Haisco Pharma’s first-aid drugs comprise cefotene hydrochloride, sodium fusidate, cefmetazole sodium, cefmenoxime hydrochloride and cefoperazone sodium tazobactam sodium. The company conducts research and development of drugs in monoclonal antibodies for anticancer, small molecular patent medicine and novel generic drugs. It operates offices in Shannan and Chengdu, China. Haisco Pharma is headquartered in Shannan, China.

Haisco Pharmaceutical Group Co Ltd (002653) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 12
Partnerships 14
Haisco Pharma Plans to Form Tibetan Medicine R&D Company Joint Venture 14
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 15
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 16
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 17
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 18
Microbion Enters into Agreement with Xizang Haisco Pharma 19
Equity Offering 20
Microbion Raises Funds through Private Placement of Shares 20
Xizang Haisco Pharma Completes IPO For US$127 Million 21
Debt Offering 22
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 22
Acquisition 23
Haisco Pharma to Acquire 60.67% Stake in Fronthera 23
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 24
Haisco Pharmaceutical Group Co Ltd – Key Competitors 25
Haisco Pharmaceutical Group Co Ltd – Key Employees 26
Haisco Pharmaceutical Group Co Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 12
Haisco Pharma Plans to Form Tibetan Medicine R&D Company Joint Venture 14
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 15
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 16
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 17
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 18
Microbion Enters into Agreement with Xizang Haisco Pharma 19
Microbion Raises Funds through Private Placement of Shares 20
Xizang Haisco Pharma Completes IPO For US$127 Million 21
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 22
Haisco Pharma to Acquire 60.67% Stake in Fronthera 23
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 24
Haisco Pharmaceutical Group Co Ltd, Key Competitors 25
Haisco Pharmaceutical Group Co Ltd, Key Employees 26
Haisco Pharmaceutical Group Co Ltd, Other Locations 27
Haisco Pharmaceutical Group Co Ltd, Subsidiaries 27

List of Figures
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Haisco Pharmaceutical Group Co Ltd (002653):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Clorox Company (CLX):企業の財務・戦略的SWOT分析
    The Clorox Company (CLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Paragon Banking Group PLC:企業の戦略・SWOT・財務情報
    Paragon Banking Group PLC - Strategy, SWOT and Corporate Finance Report Summary Paragon Banking Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Atkore International Group Inc (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Jumeirah Group:企業の戦略・SWOT・財務分析
    Jumeirah Group - Strategy, SWOT and Corporate Finance Report Summary Jumeirah Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Global Franchise Architects Co.,Ltd.:企業の戦略・SWOT・財務分析
    Global Franchise Architects Co.,Ltd. - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Architects Co.,Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Prairie Farms Dairy Inc:企業の戦略・SWOT・財務情報
    Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report Summary Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Medtronic PLC:企業の戦略・SWOT・財務情報
    Medtronic PLC - Strategy, SWOT and Corporate Finance Report Summary Medtronic PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Birchcliff Energy Ltd (BIR):石油・ガス:M&Aディール及び事業提携情報
    Summary Birchcliff Energy Ltd. (Birchcliff) is an intermediate oil and gas company that explores for, develops and produces natural gas, light oil and natural gas liquids. Its product portfolio includes crude oil, natural gas, natural gas liquids, and light and medium oils. The company operates in t …
  • Hilton Worldwide Holdings Inc:企業のM&A・事業提携・投資動向
    Hilton Worldwide Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hilton Worldwide Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • KEB Hana Bank:企業の戦略・SWOT・財務情報
    KEB Hana Bank - Strategy, SWOT and Corporate Finance Report Summary KEB Hana Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Enable Midstream Partners LP (ENBL):石油・ガス:M&Aディール及び事業提携情報
    Summary Enable Midstream Partners, LP (Enable), a subsidiary of CenterPoint Energy Inc, owns, operates, and develops natural gas and crude oil infrastructure assets. It is a limited partnership among CenterPoint Energy, OGE Energy and ArcLight Capital Partners, LLC. The company offers crude oil and …
  • Rafa Laboratories Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Rafa Laboratories Ltd (Rafa) is a pharmaceutical company that manufactures and distributes medicines and consumer health products. The company offers prescription, over-the-counter medicines, proprietary formulations, generic formulations and consumer health products. It offers scale-up and …
  • Anchor Glass Container Corp.:企業の戦略・SWOT・財務情報
    Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report Summary Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Vaxil Bio Ltd (VXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaxil Bio Ltd (Vaxil Bio), formerly Emerge Resources Corp, is a drug development company that develops immunotherapy platform. The company’s immunptherapy pipeline products include antigen specific immunotherapies, signal peptide specific antibodies and anti-infectives. It develops Vaxhit te …
  • Hurricane Energy Plc (HUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • Dare Bioscience Inc (DARE):医療機器:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • SKYCITY Entertainment Group Ltd:戦略・SWOT・企業財務分析
    SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BEKB | BCBE Private Banking:企業の戦略・SWOT・財務分析
    BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report Summary BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Manitoba Hydro-Electric Board:企業の発電所・SWOT分析2018
    Manitoba Hydro-Electric Board - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆